Postpartum thyroiditis is an autoimmune inflammation of the thyroid gland that begins in the first year after delivery, most often between two and twelve months postpartum, and affects an estimated five to ten out of every hundred Indian women — making it more common than gestational diabetes in many populations and yet far less talked about. The mechanism is straightforward. During pregnancy the maternal immune system is partially suppressed to tolerate the baby, and after delivery it rebounds, sometimes attacking the thyroid in women who already carry thyroid antibodies. The gland releases stored hormone into the blood, then runs low, then in most cases recovers.

The classic course has three phases that follow each other in sequence. A hyperthyroid phase comes first, usually starting one to three months after delivery and lasting four to eight weeks, when stored hormone leaks out of the inflamed gland. A hypothyroid phase follows between four and eight months as the damaged gland struggles to make new hormone. A recovery phase between eight and twelve months returns most women to normal thyroid function. Not every woman experiences both phases — some have only the hyper phase, some only the hypo phase, and some quietly move through both without ever knowing.

The central problem is that almost every symptom in either phase looks identical to ordinary postpartum life. Hyperthyroid palpitations and anxiety are blamed on new-mother stress. Hypothyroid fatigue and weight gain are blamed on broken sleep, breastfeeding demands and lack of time. The condition is real, common, treatable, and dramatically under-diagnosed in Indian postpartum care because almost nobody is checking the TSH unless the woman specifically asks.

The under-diagnosis of postpartum thyroiditis in India is not because the condition is rare or hard to detect — it is because nobody is looking. Indian antenatal care includes a TSH check in early pregnancy, and many OBs check again in late pregnancy, but the standard six-week postpartum visit usually focuses on perineal healing breastfeeding contraception and the baby. Thyroid function is rarely tested unless the woman raises a specific complaint, and even then, the complaint is usually heard as postpartum depression, new-mother fatigue or normal weight changes rather than as a thyroid signal.

The symptom overlap is the bigger problem. A woman three months postpartum who feels anxious, has palpitations, cannot sleep even when the baby sleeps, has lost more weight than expected and feels hot all the time is describing the hyperthyroid phase precisely, but is usually told she is stressed and needs rest. A woman seven months postpartum who is exhausted has gained weight feels cold has dry skin and is losing hair in clumps is describing the hypothyroid phase precisely, but is usually told postpartum hair loss is normal and the fatigue is from broken sleep.

The Indian family context adds another layer. Joint families often dismiss new-mother complaints as weakness or drama, women themselves are taught to push through exhaustion, and the cultural reluctance to take time off for personal health appointments means many women never get the TSH check that would settle the question. The honest fix is that any new mother with persistent symptoms in either direction — anxiety palpitations and weight loss in months one to three, or fatigue weight gain depression and cold intolerance in months four to eight — should have a TSH checked, and either the OB the GP or the woman herself can request it.

The hyperthyroid phase of postpartum thyroiditis usually starts between one and three months after delivery and lasts four to eight weeks, sometimes longer. It is caused by the inflamed thyroid releasing its stored hormone into the bloodstream, which floods the body with thyroid hormone before the supply runs out. The symptoms are the classic signs of an overactive thyroid: palpitations or a racing heart even at rest, unexpected weight loss despite eating normally or more, anxiety that feels disproportionate to circumstances, heat intolerance and excessive sweating, fine tremor of the hands, irritability with short fuse, and persistent insomnia even when the baby is sleeping.

The diagnostic trap is that almost every one of these symptoms is also a feature of ordinary new-mother life. Sleep disruption causes anxiety. Breastfeeding burns calories and causes weight loss in many women. The hormonal shifts of postpartum cause mood swings irritability and sweating. The cultural reflex in Indian families is to attribute all of this to the stress and tiredness of being a new mother, and to advise rest and dietary support rather than a blood test.

The honest signal that the picture is thyroidal rather than ordinary is the combination and the intensity. A racing heart at rest with palpable hand tremor and weight loss despite a good appetite is not normal new-mother fatigue — that is a hyperthyroid signal and deserves a TSH check. Treatment in this phase is usually supportive rather than anti-thyroid because the hyper state is self-limiting; beta-blockers like propranolol at low dose can settle the palpitations and tremor while the phase passes. Anti-thyroid drugs are not used because the gland is not overproducing hormone, it is leaking stored hormone.

The hypothyroid phase usually follows the hyper phase, starting between four and eight months postpartum and sometimes lasting four to six months or longer. It comes from the damaged thyroid being unable to produce enough new hormone after the stored supply has been released, and the symptoms are the classic signs of an underactive thyroid: persistent fatigue that is not relieved by sleep, weight gain despite no change in diet, cold intolerance even in warm weather, low mood and depression, dry skin and brittle nails, hair loss that continues beyond the usual postpartum shedding window, constipation, and a sense of slowed thinking or brain fog.

The diagnostic trap here is also severe. Postpartum fatigue is universal. Postpartum weight gain or difficulty losing weight is common. Postpartum hair loss happens to almost every woman around three to six months postpartum and is usually entirely normal telogen effluvium. Postpartum mood changes can include depression. The result is that the hypothyroid signal is regularly attributed to ordinary postpartum experience and the TSH is not checked.

The honest signal that the picture is thyroidal is again the combination and the persistence. Postpartum hair loss alone, settling within a few months, is normal. Hair loss combined with cold intolerance weight gain depression dry skin and persistent fatigue beyond six months is not normal — that pattern is a hypothyroid signal and deserves a TSH check. Treatment when TSH is above ten or when the woman is clearly symptomatic is levothyroxine, a once-daily tablet that is safe in breastfeeding and produces clear symptom improvement within two to six weeks. The dose is started low and adjusted on repeat TSH at six to eight week intervals.

Most women with postpartum thyroiditis recover normal thyroid function between eight and eighteen months after delivery, as the inflammation settles and the gland repairs itself. The recovery is gradual rather than sudden, and women who were on levothyroxine for the hypothyroid phase are usually given a trial off the medication at six to twelve months on treatment, with a repeat TSH four to six weeks later to confirm the gland is producing enough on its own. About eight out of ten women come off treatment successfully and return to normal thyroid function.

About one in five women, however, do not fully recover and go on to develop permanent hypothyroidism that needs lifelong levothyroxine. The risk of permanent hypothyroidism is higher in women who were TPO antibody positive before pregnancy or during the acute phase, who had a more severe hypothyroid phase, who needed a higher dose of levothyroxine, or who have other autoimmune conditions like type 1 diabetes or vitiligo. These women are typically told early that permanent treatment is a possibility, and the transition to lifelong therapy is straightforward.

Women who have had postpartum thyroiditis once have a substantially higher risk of having it again after a future pregnancy — roughly seven out of ten will have a recurrence. The implication is to plan a TSH check at three six and nine months postpartum after any future delivery as a routine, regardless of symptoms, and to have a low threshold for repeating the test if any symptoms appear. Long-term annual TSH monitoring is also recommended even after recovery because of the elevated risk of developing hypothyroidism years later.

Several factors substantially raise the risk of postpartum thyroiditis and identifying them in advance allows targeted testing rather than waiting for symptoms. TPO antibody positivity is the single biggest risk factor — women who tested positive for thyroid peroxidase antibodies before or during pregnancy have a five to ten times higher risk of developing postpartum thyroiditis, with around half of TPO-positive women going on to develop the condition. Any woman with a known TPO positive status should be tested at three six and nine months postpartum as a default, regardless of symptoms.

Other risk factors include prior thyroid disease in any form (previous postpartum thyroiditis, Hashimoto thyroiditis, Graves disease or even past subclinical hypothyroidism), type 1 diabetes (which carries a roughly three-fold higher risk because of shared autoimmunity), a family history of thyroid disease, age above thirty at delivery, multiple pregnancies, and a history of recurrent miscarriage which is sometimes linked to underlying autoimmune thyroid issues. Smoking is also associated with higher risk, though it is less common in Indian women.

The practical implication is to ask about these factors at the postpartum visit and to plan TSH testing accordingly. A woman with no risk factors and no symptoms does not necessarily need a default postpartum TSH, although some guidelines do now recommend universal testing at six months postpartum for all women. A woman with even one risk factor — TPO positive prior thyroid history type 1 diabetes family history or any persistent symptoms — should have the TSH check made part of her postpartum care plan.

The simplest screening test for postpartum thyroiditis is a serum TSH, which costs one hundred and fifty to four hundred rupees at private labs like Dr Lal Path Labs Metropolis or Thyrocare, and is free at most government primary health centres under the antenatal and postpartum care programmes. The test does not need fasting, can be done at any time of day, and gives a result within twenty-four hours. If the TSH is abnormal the next step is to add free T4 free T3 and TPO antibodies to the next sample to characterise the picture more fully, which adds five hundred to fifteen hundred rupees.

The recommended schedule for women with any risk factor is a TSH at three six and nine months postpartum. For women with known TPO positivity or prior postpartum thyroiditis the same three checks are non-negotiable. For women with no risk factors and no symptoms, some guidelines (including more recent endocrine society recommendations) advise a single TSH at six months postpartum as a default screen for all women, although this is not yet standard Indian practice. Any new mother with persistent symptoms in either direction at any postpartum time point should have a TSH regardless of schedule.

Interpretation in postpartum is the same as in the general adult population for most purposes. A TSH below the lower reference limit with elevated free T4 fits the hyperthyroid phase. A TSH above ten with low or low-normal free T4 fits the hypothyroid phase and usually triggers treatment. A TSH between the upper reference limit and ten is subclinical hypothyroidism and is treated based on symptoms TPO status and breastfeeding plans, with most clinicians treating symptomatic women in this range.

Treatment of postpartum thyroiditis is phase-specific and most women need either no treatment or a single class of medication for a limited period. The hyperthyroid phase is generally not treated with anti-thyroid drugs because the gland is not making excess hormone — it is leaking stored hormone — and anti-thyroid drugs like methimazole or propylthiouracil would not work. Symptomatic treatment with a low dose of a beta-blocker like propranolol (ten to forty milligrams two or three times a day) settles the palpitations tremor and anxiety while the phase resolves on its own over four to eight weeks. Propranolol is safe in breastfeeding in small amounts.

The hypothyroid phase is treated with levothyroxine when the TSH is above ten or when the woman is clearly symptomatic with a TSH between the upper reference limit and ten. The dose is typically started at twenty-five to fifty micrograms daily and adjusted on repeat TSH at six to eight week intervals to bring the TSH into the lower half of the normal range. Common Indian brands include Eltroxin (GSK), Thyronorm (Abbott), Thyrox and Thyrofit, all of which are equivalent at the same dose. Levothyroxine is taken first thing in the morning on an empty stomach with water and no food or other medication for thirty to sixty minutes.

After four to six months on levothyroxine many women are given a trial off the medication to see whether the thyroid has recovered, with a repeat TSH four to six weeks later. Women who do not need to come off treatment, who have persistent abnormal TSH, or who develop new symptoms during the trial are continued on levothyroxine indefinitely. The transition to permanent therapy is straightforward and is the right outcome for the roughly twenty percent of women who develop permanent hypothyroidism after postpartum thyroiditis.

The full diagnostic and treatment pathway for postpartum thyroiditis in India is genuinely affordable and accessible, which makes the under-diagnosis even harder to justify. A serum TSH at Dr Lal Path Labs Metropolis Thyrocare or SRL costs one hundred and fifty to four hundred rupees and is available with home collection in most urban and tier-two cities for an extra fifty to one hundred rupees. The same test is free at government primary health centres community health centres and district hospitals under the postpartum care programme. A TPO antibody test costs five hundred to twelve hundred rupees at private labs and is usually only added if the initial TSH is abnormal.

Treatment costs are also low. Levothyroxine in standard brands like Eltroxin (GSK), Thyronorm (Abbott), Thyrox or Thyrofit costs around fifty to two hundred rupees per month at standard doses of fifty to one hundred micrograms daily, and is widely available at any pharmacy with a prescription. Beta-blockers like propranolol cost around thirty to one hundred rupees per month. Generic versions of both medications are available at Jan Aushadhi stores and government dispensaries at substantially lower prices.

Endocrinologist consultations cost eight hundred to three thousand rupees at private hospital chains like Apollo Fortis Manipal and Max, depending on the city and seniority of the doctor, and are free at AIIMS and government medical college hospitals though with longer wait times. Most cases of postpartum thyroiditis are managed adequately by an OB GP or family physician without needing endocrinology referral, with referral reserved for atypical presentations, severe symptoms, or persistent abnormalities. Telemedicine consultations via Practo Tata 1mg or government eSanjeevani are a low-cost option for follow-up TSH review and dose adjustment.

All standard treatments for postpartum thyroiditis are compatible with breastfeeding, which is a relief for the many women who develop the condition while exclusively breastfeeding or during the breastfeeding window. Levothyroxine is the preferred treatment for the hypothyroid phase and is fully safe in breastfeeding — it is identical to the thyroid hormone the body makes naturally, crosses into breast milk only in trace amounts, and is in fact the same hormone the baby would receive across the placenta during pregnancy. There is no reason to stop or reduce breastfeeding for levothyroxine, and adequate maternal thyroid hormone is actually important for milk supply.

Beta-blockers like propranolol pass into breast milk in small amounts and are considered safe at the low doses used for hyperthyroid symptom relief. Propranolol is preferred over atenolol because less of it transfers and it has been more extensively studied in breastfeeding. If the baby is preterm or has heart or breathing problems the choice may be discussed more carefully with the paediatrician, but for healthy term infants the standard dose is not a concern.

Anti-thyroid drugs are very rarely needed in postpartum thyroiditis because the hyper phase is self-limiting, but if they are used for any reason both propylthiouracil and methimazole are compatible with breastfeeding. Propylthiouracil is sometimes preferred in early breastfeeding because less of it transfers into milk, while methimazole at lower doses is also considered acceptable. Radioactive iodine therapy is absolutely contraindicated in breastfeeding and is not used for postpartum thyroiditis anyway because the condition resolves on its own.